Integrated Investment Consultants LLC Purchases Shares of 16,104 CVS Health Co. (NYSE:CVS)

Integrated Investment Consultants LLC acquired a new position in shares of CVS Health Co. (NYSE:CVS - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 16,104 shares of the pharmacy operator's stock, valued at approximately $1,013,000.

Other large investors also recently added to or reduced their stakes in the company. Cypress Capital Group grew its position in CVS Health by 5.1% during the third quarter. Cypress Capital Group now owns 6,654 shares of the pharmacy operator's stock valued at $418,000 after purchasing an additional 320 shares in the last quarter. Landscape Capital Management L.L.C. boosted its stake in shares of CVS Health by 45.4% during the 3rd quarter. Landscape Capital Management L.L.C. now owns 75,524 shares of the pharmacy operator's stock valued at $4,749,000 after buying an additional 23,594 shares during the period. Intech Investment Management LLC grew its holdings in shares of CVS Health by 70.5% during the 3rd quarter. Intech Investment Management LLC now owns 96,520 shares of the pharmacy operator's stock valued at $6,069,000 after acquiring an additional 39,919 shares in the last quarter. Payden & Rygel acquired a new position in shares of CVS Health in the third quarter worth $6,282,000. Finally, Pzena Investment Management LLC raised its holdings in shares of CVS Health by 1.5% during the third quarter. Pzena Investment Management LLC now owns 13,135,308 shares of the pharmacy operator's stock worth $825,948,000 after acquiring an additional 198,920 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Price Performance

CVS traded up $0.91 during trading on Friday, hitting $58.01. 10,428,506 shares of the stock traded hands, compared to its average volume of 11,356,283. The business has a 50 day moving average price of $59.21 and a 200 day moving average price of $58.59. The company has a market cap of $73.00 billion, a price-to-earnings ratio of 14.72, a PEG ratio of 0.94 and a beta of 0.55. CVS Health Co. has a twelve month low of $52.71 and a twelve month high of $83.25. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts' consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion for the quarter, compared to analysts' expectations of $92.72 billion. During the same quarter in the previous year, the firm posted $2.21 earnings per share. The company's revenue was up 6.3% on a year-over-year basis. Equities research analysts forecast that CVS Health Co. will post 5.43 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.59%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health's dividend payout ratio is presently 67.51%.

Analyst Ratings Changes

Several research analysts have weighed in on the company. StockNews.com lowered CVS Health from a "hold" rating to a "sell" rating in a research report on Thursday, November 14th. Deutsche Bank Aktiengesellschaft dropped their price objective on CVS Health from $64.00 to $63.00 and set a "hold" rating on the stock in a report on Friday, August 9th. Evercore ISI lifted their target price on shares of CVS Health from $62.00 to $75.00 and gave the company an "outperform" rating in a research note on Tuesday, October 8th. Truist Financial restated a "buy" rating and set a $67.00 price target (down previously from $76.00) on shares of CVS Health in a research note on Wednesday. Finally, Mizuho decreased their price objective on shares of CVS Health from $73.00 to $66.00 and set an "outperform" rating for the company in a report on Thursday, October 24th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $72.28.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.